Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8734053 | HIV & AIDS Review | 2016 | 5 Pages |
Abstract
In this large cohort of HIV infected patients with high baseline H1N1 seroprotective titers only a moderate antibody response to a single vaccination with H1N1pdm09 AS03-adjuvanted vaccine was detected. Emerging influenza pandemics warrant usage of booster vaccinations in order to achieve higher immunogenicity to protect a vulnerable patient population such as HIV positive individuals against influenza.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
C. Schwarze-Zander, B. Steffens, J. Emmelkamp, T. Kümmerle, C. Boesecke, J.C. Wasmuth, C.P. Strassburg, G. Fätkenheuer, J.K. Rockstroh, A.M. Eis-Hübinger,